ImmuCell Corporation (NASDAQ: ICCC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT IMMUCELL CORPORATION

ImmuCell Corporation (NASDAQ: ICCC)
Listen to this Section


$9.60
-0.2750 ( -2.79% ) 7.5K

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Market Data


Open $9.60
Previous Close $9.87
Volume 7.5K
Market Cap $90.92M
Day Range $9.44 - $9.92
52 Week Range $4.52 - $10.75
Shares Outstanding 9.05M
Change % -2.79%
Net Change ▼ -0.2750
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year1987
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -17,100.00

Date Type Amount Purchased Purchaser
2025-06-12 Buy 1000.00 Gathagan Bryan K.
2023-09-06 Sale -3100.00 Tomsche David Scott
2023-08-30 Sale -15000.00 Gathagan Bryan K.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 90 Nov 13, 2025
8-k 8K-related 14 Nov 13, 2025
4 Insider transactions 1 Nov 12, 2025
3 Insider transactions 1 Nov 07, 2025
8-k 8K-related 14 Nov 04, 2025
8-k 8K-related 14 Oct 07, 2025
8-k 8K-related 16 Sep 30, 2025
8-k 8K-related 14 Aug 25, 2025
8-k 8K-related 13 Aug 14, 2025
10-q Quarterly Reports 92 Aug 14, 2025

Latest News


× Before browsing our site, please accept our cookies policy